Immunovant, Inc.
USD38.52
+0.01 (+0.03%)
CEO
Eric Venker
IPO Date
2019-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.61
Prev. Close
$38.51
Day Low
$38.24
Day High
$39.13
52W Low
$14.32
52W High
$39.28
Market Cap
$7.91B
Volume
0.61M
| 2,966 |
| $38.95 |
| 26 Jun 2026 | Stout Jay S | Chief Technology Officer | S-Sale | Disposed | 33,277 | $38.18 |
| 26 Jun 2026 | Stout Jay S | Chief Technology Officer | S-Sale | Disposed | 6,723 | $38.94 |
| 26 Jun 2026 | Van Tuyl Christopher | Chief Legal Officer | M-Exempt | Acquired | 17,824 | $15.20 |
| 26 Jun 2026 | Van Tuyl Christopher | Chief Legal Officer | S-Sale | Disposed | 14,982 | $38.19 |
| 26 Jun 2026 | Van Tuyl Christopher | Chief Legal Officer | S-Sale | Disposed | 2,842 | $38.96 |
| 26 Jun 2026 | Van Tuyl Christopher | Chief Legal Officer | M-Exempt | Disposed | 17,824 | $15.20 |
| 26 Jun 2026 | Girao Tiago | Chief Financial Officer | M-Exempt | Acquired | 10,000 | $15.90 |
| 26 Jun 2026 | Girao Tiago | Chief Financial Officer | S-Sale | Disposed | 10,000 | $38.46 |